Aktiespot

Par Drugs and Chemicals Limited (PAR DRUGS AND CHEM LTD) Aktie

PAR.NS

Geschlossen
₹89.89+3.18 (+3.67%)
Chart wird geladen...

PAR DRUGS AND CHEM LTD

Eröffnung87.00
Hoch90.00
Tief87.00
Volumen2.31k
P/E8.44
Marktkapitalisierung1.11B
52-Wochen-Hoch122.43
52-Wochen-Tief78.05
Durchschn. Volumen16.38k
DividendeN/A
BetaN/A
EPS10.65

Über Par Drugs and Chemicals Limited (PAR DRUGS AND CHEM LTD) Aktie

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Unternehmensinformationen

Börse: NSE (NSI)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
816, Nilamber Triumph
390007 Vadodara, India
Telefon: + 91 26 5299 1022

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: